Answer
Gemfibrozil increases repaglinide exposure and prolongs its blood-glucose-lowering effects, increasing the risk of severe hypoglycaemia, so their co-administration is contraindicated.
Sources for this answer
- Lopid 600 mg film-coated tabletPfizer Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 11Document updated
Sources checked